BACK TO TOP
ATOMIC: The Academic Thoracic Oncology Medical Investigators Consortium

 

CAPABILITIES OF THE ACADEMIC THORACIC ONCOLOGY MEDICAL INVESTIGATORS CONSORTIUM

Overview:

The Academic Thoracic Oncology Medical Investigators Consortium is a full service organization positioned to design, perform and analyze clinical trials focused on thoracic and lung cancers. Consortium Investigators have demonstrated expertise in the natural history and molecular basis of thoracic and lung malignancies.

Central Coordination:

The Academic Thoracic Oncology Medical Investigators Consortium possesses an experienced centralized research department that integrates coordinated project management, finance, contract and grant management capabilities. This highly effective infrastructure allows for rapid study development, start-up and enrollment, as well as the capabilities to perform all phases of clinical trials.

Sponsor Advantages:

The Academic Thoracic Oncology Medical Investigators Consortium offers an innovative and focused research model that speeds decision making by the sponsor on development of drugs targeted to thoracic and lung cancers.

Site Expertise:

World class investigators and institutions were selected through a highly competitive process that focused specifically on an exemplary combination of qualifications. Each member institution possesses the following attributes:

  • An established and vigorous cancer treatment program.

  • A demonstrated commitment to cancer treatment, especially through community access, professional support and multi-organizational communication.

  • A mature clinical research program with a substantial support infrastructure.

  • Outstanding and nationally recognized laboratory, treatment and research facilities.

  • Clinicians who are leaders in cancer research and treatment.

  • Ability to contribute to translational research endpoints.

  • A Principal Investigator who is a renowned clinical research leader.

 

GET TO KNOW US!

DOWNLOAD OUR BROCHURE